Chemoinformaics analysis of 1-Methyl-2-[(6Z,9Z)-6,9-pentadecadienyl]-4(1H)-quinolone
| Molecular Weight | 365.561 | nRot | 12 |
| Heavy Atom Molecular Weight | 330.281 | nRig | 14 |
| Exact Molecular Weight | 365.272 | nRing | 2 |
| Solubility: LogS | -2.808 | nHRing | 1 |
| Solubility: LogP | 5.534 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 35 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 11 |
| nHA | 2 | APOL | 66.9898 |
| nHD | 0 | BPOL | 37.6902 |
| QED | 0.302 |
| Synth | 2.565 |
| Natural Product Likeliness | 0.915 |
| NR-PPAR-gamma | 0.59 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.021 |
| CACO-2 | -4.828 |
| MDCK | 0.0000234 |
| BBB | 0.704 |
| PPB | 0.991693 |
| VDSS | 2.124 |
| FU | 0.00716727 |
| CYP1A2-inh | 0.303 |
| CYP1A2-sub | 0.707 |
| CYP2c19-inh | 0.585 |
| CYP2c19-sub | 0.322 |
| CYP2c9-inh | 0.324 |
| CYP2c9-sub | 0.952 |
| CYP2d6-inh | 0.58 |
| CYP2d6-sub | 0.948 |
| CYP3a4-inh | 0.753 |
| CYP3a4-sub | 0.131 |
| CL | 4.287 |
| T12 | 0.799 |
| hERG | 0.463 |
| Ames | 0.819 |
| ROA | 0.061 |
| SkinSen | 0.965 |
| Carcinogencity | 0.363 |
| EI | 0.918 |
| Respiratory | 0.801 |
| NR-Aromatase | 0.25 |
| Antiviral | Yes |
| Prediction | 0.812609 |